Companies / Autolus Therapeutics plc

Autolus Therapeutics plc

Nasdaq: AUTLForeign · IFRSCIK 1730463LONDON

Financials · FY2025

Revenue$75.39M
Net income$-287.53M
Total debt$0
Cash$171.41M
Diluted EPS$-1.08
Shares outstanding266.2M

Ownership

266.2M shares outstanding · as of Aug 10, 2026
17.8%10%+ / strategic
Ownership
10%+ / strategic17.85%47,505,343
Institutions46.43%123,585,644
Public float35.72%95,071,553

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 21

View all →
Insider% of sharesShares
Azelby RobertDirector
——
Bain LindaDirector
——
Berriman John EDirector
——
Bonney Michael WDirector
——
Butitta Cynthia MDirector
——
Dolski RobertChief Financial Officer
——
Driggs AlexSVP, Legal Affairs and GC
——
Iannone RobertDirector
——
Itin ChristianCEOChief Executive Officer · Director
——
Leiderman ElisabethDirector
——

Institutional holders 93

View all →
HolderValue% of shares
Mak Capital One LLC$46.40M12.63%
Armistice Capital, LLC$34.83M6.57%
Blackstone Inc$28.27M7.70%
Syncona Portfolio Ltd$26.63M6.25%
Tetragon Partners GP Ltd$18.91M3.57%
Schroder Investment Management Group$12.05M3.57%
Frazier Life Sciences Management, L.P.$9.20M1.74%
Laurion Capital Management LP$4.58M1.25%
Bank of America Corp /De$3.90M0.74%
Renaissance Technologies LLC$3.17M0.86%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Blackstone Inc
13F manager
NewADR$28.27M+20.5M
20,485,611
7.70% of shares
medium
Q1 2026
as of
Mak Capital One LLC
13F manager
AddADR$4.99M+3.6M
+12.05%
33,621,487
12.63% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimADR$-3.33M-2.1M
-56.50%
1,603,458
0.60% of shares
low
Q1 2026
as of
Atle Fund Management AB
13F manager
ExitADR$-2.33M-1.2M
-100.00%
0
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewADR$1.34M+972K
971,691
0.37% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimADR$-1.11M-806K
-25.95%
2,299,499
0.86% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
TrimADR$-336.2K-244K
-90.13%
26,682
0.01% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
NewADR$282.5K+205K
204,728
0.08% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
MAK Capital Fund LPPassive13G/A—30,005,343—
Armistice Capital, LLCPassive13G/A—17,500,000—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AUTLADREquity05280R100BBG00KVT05R6